Atlas Trials

Spruce Biosciences

8 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Spruce Biosciences

RecordFirmDate
Intracerebroventricular Tralesinidase Alfa in Participants With MPS IIIB (Sanfilippo Syndrome Type B) (NCT07579910)Spruce Biosciences2026-12-01
A Study of Safety and Efficacy of Tildacerfont in Females With Polycystic Ovary Syndrome and Elevated Adrenal Androgens (NCT05370521)Spruce Biosciences2022-05-15
A Phase 2 Study to Evaluate the Safety, Efficacy and PK of Tildacerfont in Children Aged 2-17 Years With CAH (NCT05128942)Spruce Biosciences2021-12-10
A Ph2b to Evaluate Tildacerfont in the Reduction of Glucocorticoid Steroid Doses in Adult CAH (NCT04544410)Spruce Biosciences2021-02-22
A Ph2b to Evaluate Clinical Efficacy and Safety of Tildacerfont in Adult CAH (NCT04457336)Spruce Biosciences2020-08-26
Study to Evaluate the Safety and Efficacy of SPR001 in Subjects With Classic Congenital Adrenal Hyperplasia (NCT03687242)Spruce Biosciences2018-09-06
Study of SPR001 in Adults With Classic Congenital Adrenal Hyperplasia (NCT03257462)Spruce Biosciences2017-07-12
Early Access Treatment With Tralesinidase Alfa in Mucopolysaccharidosis Type IIIB (Sanfilippo Syndrome Type B) (NCT07733856)Spruce Biosciences

Track Spruce Biosciences automatically

Every clearance here is in the API, with alerts when new ones post.